Oral Oncology
Volume 40, Issue 1 , Pages 56-62 , January 2004

Surveillance of basaloid oral squamous cell carcinoma: the value of [18F]FDG-PET

  • Martin Kunkel

      Affiliations

    • Department of Oral and Maxillofacial Surgery, University Hospital Mainz, Augustusplatz 2, 55101 Mainz, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-6131-173191; fax: +49-6131-176602
    • ,
  • Andreas Helisch

      Affiliations

    • Department of Nuclear Medicine, University Hospital Mainz, Langenbeckstr. 1, 55101 Mainz, Germany
    • ,
  • Torsten E Reichert

      Affiliations

    • Department of Oral and Maxillofacial Surgery, University Hospital Mainz, Augustusplatz 2, 55101 Mainz, Germany
    • ,
  • Peter Bartenstein

      Affiliations

    • Department of Nuclear Medicine, University Hospital Mainz, Langenbeckstr. 1, 55101 Mainz, Germany
    • ,
  • Wilfried Wagner

      Affiliations

    • Department of Oral and Maxillofacial Surgery, University Hospital Mainz, Augustusplatz 2, 55101 Mainz, Germany

Received 23 April 2003 ,Accepted 13 June 2003.

References 

  1. Banks ER, Frierson HF, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and the neck (a clinicopathologic an immunohistochemical study). Am J Surg Pathol. 1992;16:939–946
  2. Wain SL, Kier R, Vollmer RT, Bossen RT. Basaloid-squamous carcinoma of the tongue, hypopharynx and larynx (report of 10 cases). Hum Pathol. 1986;17:1158–1166
  3. Ide F, Shimoyama T, Hone N, Kusama K. Basaloid squamous cell carcinoma of the oral mucosa (a new case and review of 45 cases in the literature). Oral oncology. 2002;38:120–124
  4. Coletta RD, Cotrim P, Almeida OP, Alves VAF, Wakamatsu A, Vargas PA. Basaloid squamous carcinoma of oral cavity (a histologic and immunohistochemical study). Oral Oncology. 2002;38:723–729
  5. Wieneke JA, Thompson LDR, Wenig BM. Basaloid squamous cell carcinoma of the sinonasal tract. Cancer. 1999;85:841–854
  6. Grötz KA, Kuffner HD, Mitze M, Reichert T, Wagner W. Das basaloide Plattenepithelkarzinom (BSC) der Mundschleimhaut. Mund Kiefer GesichtsChir. 1997;1:137–145
  7. Keyes JW, Watson NE, Williams DW, Greven KM, McGuirt WF. FDG PET in head and neck cancer. AJR Am J Roentgenol. 1997;169:1663–1669
  8. Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wieser S, Heinisch M, et al. Evaluation of head and neck cancer with 18F-FDG PET (a comparison with conventional methods). Eur J Nucl Med. 2001;28:816–821
  9. Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000;18:651–658
  10. Bier J. Definitionen zum radikalchirurgischen Vorgehen bei Plattenepithelkarzinomen der Mundhöhle. Dtsch Z Mund Kiefer GesichtsChir. 1981;6:369–372
  11. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose (variations with body weight and a method for correction). Radiology. 1993;189:847–850
  12. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck. 2001;23:147–159
  13. Smith BD, Haffty BC. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat Oncol Invest. 1999;7:125–144
  14. Wong RJ, Lin DT, Schöder H, Patel SG, Gonen M, Wolden S, et al. Diagnostic and prognostic value of [18F]Fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002;20:4199–4208
  15. Terhaard CH, Bongers V, Rijk PP, Hordijk G-J. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck. 2001;23:933–941

PII: S1368-8375(03)00135-0

doi: 10.1016/S1368-8375(03)00135-0

Oral Oncology
Volume 40, Issue 1 , Pages 56-62 , January 2004

Article Tools

* Image Usage & Resolution